CStone Pharmaceuticals Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2588M1006
HKD
5.91
-0.01 (-0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 12.64% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -359.62
2

Negative results in Jun 25

3

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 7,778 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.84

stock-summary
Return on Equity

-112.58%

stock-summary
Price to Book

22.54

Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2018)
Net Profit:
-176 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.8%
0%
-2.8%
6 Months
-36.31%
0%
-36.31%
1 Year
118.89%
0%
118.89%
2 Years
283.77%
0%
283.77%
3 Years
48.49%
0%
48.49%
4 Years
-8.09%
0%
-8.09%
5 Years
-45.88%
0%
-45.88%

CStone Pharmaceuticals Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
194.13%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-359.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.47
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
40.04
EV to EBIT
-33.69
EV to EBITDA
-38.66
EV to Capital Employed
240.18
EV to Sales
61.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-713.01%
ROE (Latest)
-113.92%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by CStone Pharmaceuticals Co. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -13.85% vs -8.45% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 75.63% vs 61.34% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "441.50",
          "val2": "512.50",
          "chgp": "-13.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-49.40",
          "val2": "-604.90",
          "chgp": "91.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.40",
          "val2": "13.10",
          "chgp": "25.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.70",
          "val2": "0.30",
          "chgp": "-1,666.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-98.90",
          "val2": "-405.80",
          "chgp": "75.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-234.20%",
          "val2": "-1,305.50%",
          "chgp": "107.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
441.50
512.50
-13.85%
Operating Profit (PBDIT) excl Other Income
-49.40
-604.90
91.83%
Interest
16.40
13.10
25.19%
Exceptional Items
-4.70
0.30
-1,666.67%
Consolidate Net Profit
-98.90
-405.80
75.63%
Operating Profit Margin (Excl OI)
-234.20%
-1,305.50%
107.13%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -13.85% vs -8.45% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 75.63% vs 61.34% in Dec 2023

stock-summaryCompany CV
About CStone Pharmaceuticals Co. Ltd. stock-summary
stock-summary
CStone Pharmaceuticals Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available